TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC)
Treos Bio presented new clinical data at the EACR 2026 conference regarding its PEPI technology. The findings highlight successful outcomes in treating MSS metastatic colorectal cancer, including a six-year cancer-free case.
Why it matters
Advancements in off-the-shelf immunotherapy for difficult-to-treat cancers represent a significant potential breakthrough in oncology.
TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC) Sign In New user? Click Here Subscribe Sign In New user? Click Here OPINION NEWS REGIONS WORLD BUSINESS SPORTS ENTERTAINMENT LIFESTYLE THE SUNDAY TIMES SPECIAL FEATURES SPECIAL SECTIONS TMT NEWSWIRE Media OutReach Newswire PR Newswire GlobeNewswire Plentisoft FAST TIMES LEGAL ADVICE CAMPUS PRESS VIDEOS EXPATS & DIPLOMATS PHOTOS BUSINESS FORUM PODCASTS RESOURCES WEATHER MARKET OVERVIEW The Manila Times 500 EXAM RESULTS TMT DIGITAL EDITION TMT CSI TMT 127TH ANNIVERSARY QUIZZES GAMES more OPINION NEWS REGIONS WORLD BUSINESS SPORTS ENTERTAINMENT LIFESTYLE THE SUNDAY TIMES SPECIAL FEATURES SPECIAL SECTIONS TMT NEWSWIRE Media OutReach Newswire PR Newswire GlobeNewswire Plentisoft FAST TIMES LEGAL ADVICE CAMPUS PRESS VIDEOS EXPATS & DIPLOMATS PHOTOS BUSINESS FORUM PODCASTS RESOURCES WEATHER MARKET OVERVIEW The Manila Times 500 EXAM RESULTS TMT DIGITAL EDITION TMT CSI TMT 127TH ANNIVERSARY QUIZZES GAMES OPINION NEWS REGIONS WORLD BUSINESS SPORTS ENTERTAINMENT LIFESTYLE THE SUNDAY TIMES SPECIAL FEATURES SPECIAL SECTIONS TMT NEWSWIRE Media OutReach Newswire PR Newswire GlobeNewswire Plentisoft FAST TIMES LEGAL ADVICE CAMPUS PRESS VIDEOS EXPATS & DIPLOMATS PHOTOS BUSINESS FORUM PODCASTS RESOURCES WEATHER MARKET OVERVIEW The Manila Times 500 EXAM RESULTS TMT DIGITAL EDITION TMT CSI TMT 127TH ANNIVERSARY QUIZZES GAMES TMT Newswire GlobeNewswire TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC) By GlobeNewswire June 9, 2026 Resize Small Medium Large Three presentations highlight off-the-shelf immunotherapy in Microsatellite Stable (MSS) mCRC, biopsy-free target selection and broader platform potential across difficult-to-treat cancers
The article is a straightforward report on clinical trial results provided by a corporate press release.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in